Bangladesh develops country’s first GMO rice variety

biotech

Scientists in Bangladesh have developed the country’s first biotech rice variety giving farmers an answer to the difficulties they face in harvesting the staple with machines.

Stems of BRRIdhan-86, the variety that got release approval yesterday, are strong and stout and easy to reap by mechanical harvesters. This will come handy to farm owners, who have dearth of labourers and also find it difficult to use harvesters.

BRRI breeders told UNB that the new variety, with half a tonne of extra yield potential per hectare over the country’s most produced rice variety BRRIdhan-28, is derived from Iranian rice variety Niamat through application of a biotech tool called anther culture.

Anther culture, applied for the first time in rice science in Bangladesh, is a biotech plant culturing technique where immature pollens are made to divide and grow into tissues either on solid and liquid medium.

The scientists at the Bangladesh Rice Research Institute (BRRI) have also developed a new rice variety with the highest ever zinc (27.6 mg/kg) content. BRRIdhan-84 also got approval along with three more new rice varieties yesterday.

The prospect of higher rice yield through the release of the new varieties also comes against the backdrop of diminishing returns from the country’s rice fields.

Read full, original post: Country’s first biotech rice released

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Jul-8-2026-12_32_48-PM
Viewpoint: SCOTUS strikes a blow against junk science in Bayer glyphosate case. Will it deter mass tort litigators?
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-07-08-at-9.36.03-AM
Viewpoint: Long-contained diseases are on the rise in the U.S. Are Trump cuts to blame?
afb-a-b
As the EU loosens restrictions on agricultural gene editing, it remains years behind the rest of the world on equally-safe GMO foods
Viewpoint: Consensus as truth? How ‘misinformation police’ control policy narratives
Which among war, weather and cyber attacks is the biggest world threat? None of the above. It’s misinformation, and here’s why.
c9f0a584-46e9-4dd8-9a77-f5f5a7a51a84
Across Eastern Europe, science disinformation has spread far beyond COVID and vaccine denialism. Here’s the grim list.
Screenshot 2026-07-11 100209
Viewpoint: Supplements to clean your liver? Not a good idea.
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jul-7-2026-01_57_55-PM
Viewpoint: Europe’s rejection of air conditioning is the poster child for misunderstanding how to mitigate the impact of climate change
Gemini_Generated_Image_gabo48gabo48gabo
Viewpoint: A plastic surgeon on why banning gender-transition surgery without further research is wrong and harmful
ChatGPT-Image-Jul-1-2026-03_33_49-PM
‘Alternative’ cancer treatments that could kill you
ChatGPT-Image-Jul-1-2026-12_37_08-PM
Viewpoint: Trump poised to politicize all U.S.-supported science research
Screenshot-2026-07-10-at-3.10.50-PM
Snake-oil cures throughout history
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.